MDC is a Stanford spinout developing the most advanced surgical robot to destroy soft tissue cancer at its earliest stage. We are building an MRI-compatible robotic system for real-time, teleoperated interventions, starting with cancer biopsies and ablations. Our system allows interventional radiologists to operate inside the MRI bore from the MRI control room with sub-millimeter precision and haptic feedback. This enables real-time, image-guided targeting of small tumors at their earliest and most curable stage. The platform is scalable from manual teleoperation to AI-assisted autonomy, unlocking faster procedures, improved outcomes, and the digitization of interventional workflows.
